Skip to main content

Obesity Management Market Synopsis, Diagnosis, Treatment and Technology Report 2020

Obesity Management Market for weight loss and diet Insights 2019 by Type [Medication (Orlistat, Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone and Liraglutide) and Surgery (Laparoscopic Adjustable Gastric Band, Gastric Sleeve and Gastric Bypass)] and Regional Analysis, size, Share, Technology, Growth Trends  and Forecast To 2025.
The “Obesity Management Market size is expected to register 8.4% CAGR, expected to be valued at USD 9.34 Billion in 2025.”, states the latest Market Research Future (MRFR) report.
Obesity Management Market Overview
Obesity is a chronic condition that is characterized by excessive storage and accumulation of fats in the body. It is measured by the body mass index (BMI). Obesity, along with affecting the appearance of a person also results in chronic diseases. Obesity management includes therapies, products, and services that help in reducing and managing weight in those suffering from obesity.
Key Players 
Key players have used different strategies to create a niche in the market
such as mergers and acquisitions, expansions, partnerships and more. These are the Notable players profiled in the obesity management market report:
  • Pfizer Inc. (US)
  • and Merck Sharp & Dohme Corp.
  • subsidiary of Merck & Co. Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Herbalife Ltd. (US)
  • Apollo Endosurgery (US)
  • AstraZeneca (UK)
  • Ethicon Inc. (US)
  • and Others.
Obesity Management Market Segmentation
The Market Research Future report provides an all-inclusive segmental analysis of the obesity management market on the basis of lifestyle changes, surgery, and prescription.
  • the obesity management market is segmented By prescription,
    • liraglutide (Saxenda)
    • bupropion and naltrexone (Contrave)
    • phentermine and topiramate (Qsymia)
    • lorcaserin (Belvig)
    • orlistat (Xenical)
    • and others.
  • the obesity management market is segmented By surgery,
    • biliopancreatic diversion with dietary switch
    • laparoscopic adjustable gastric banding
    • gastric bypass surgery
    • and Others
  • the obesity management market is segmented By lifestyle changes,
    • exercise
    • dietary changes
    • and others.
Access the Premium Research Details along with Complete TOC@ https://www.marketresearchfuture.com/reports/obesity-management-market-2690
Industry News 
October 2019: International and local, regional faculty of multi-disciplinary experts recently gathered in Abu Dhabi for the 2019 UAE Obesity Conference for discussing and sharing latest trends in obesity management and treatment under the theme titled “It’s time to act upon obesity.” There were presentations for raising obesity pandemic awareness and its associated diseases. Participants analyzed obesity challenges, childhood obesity, and surgical and medical management of obesity.  
LIST OF FIGURES
FIGURE 1 RESEARCH PROCES
FIGURE 2 MARKET STRUCTURE OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 3 MARKET DYNAMICS OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 4 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY TYPE, 2018 (%)
FIGURE 5 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 7 AMERICAS: OBESITY MANAGEMENT MARKET SHARE BY REGION, 2018 (%)
FIGURE 6 NORTH AMERICA: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 7 EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 8 WESTERN EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 9 ASIA-PACIFIC: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
Continued…
By region, the obesity management market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Medical Billing Outsourcing Market Briefing 2020 By New Developments, Diagnosis by Key Applications

Medical Billing Outsourcing Market Research Report: Information by Component (In House & Outsourced), Service (Front End Service, Middle End Service, & Back End Service), End User (Hospitals, Physician’s Office, & Others) — Global Forecast till 2023 Global Medical Billing Outsourcing Market   In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue Major Key Players The key strategies followed by the players operating in the global Medical Billing Outsourcing Market were innovation, product development, acquisition, and expansion. R1 RCM Inc. Allscripts Cerner Corporation EClinical Works Experian Information Solutions Inc. GENERAL ELECTRIC COMPANY Genpact HCL Technologies Limited Kareo, Inc. McKesson Corporation Quest Diagnostics Incorporated The ...
Post a Comment
Read more

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Factors,Leading Players, Clinical Reviews and Research Report

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 The  Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Marke...
Post a Comment
Read more